Following the Ethics Committee approval (Ref: IR.IUMS.FMD.REC.1398.107) and receipt of the clinical trial registration code (Ref: IRCT20190929044924N1), written informed consent was obtained from the parents before the enrollment of children in this study. Forty-six pediatric patients (both sexes) aged 3 - 6 years, with ASA I-II, who were candidates for lower abdomen surgery, for 30 minutes to two hours under general anesthesia, were included in this double-blind, randomized clinical trial. The exclusion criteria for the study consisted of problematic surgeries (i.e., blood transfusion due to unacceptable bleeding), sacral deformities, hemorrhagic disorders, infections (local or systemic), history of drug hypersensitivity, and refusal of parents. The sample size of 46 patients was obtained using the following formula, who were randomly divided into two groups of 23:
To double-blind the study, the children’s parents and the researchers were kept unaware of the group classification.
The induction and maintenance of anesthesia were performed in the same manner for both groups (including propofol, fentanyl, and atracurium for induction and isoflurane for maintenance). After surgery and before extubation, a caudal epidural block was performed under an aseptic situation, by lateral decubitus position, using a 20 G needle (Pajunk, Germany) under ultrasonography with a high frequency (6 - 13 MHz) linear probe (Sonosite, USA). When the exact location of the needle tip was confirmed by the sonographic view, 2 - 4 mL was slowly administered. If there were not any blood pressure and heart rate alterations, the remainder of the injectable solution was administered slowly.
Patients were randomly divided into two equal groups, R and TR. The injectable solution was 0.2% ropivacaine 1 mL/kg (Ropivacaine, Molteni, Italy) up to the highest volume of 15 mL in the R group and 0.2% ropivacaine 1 mL/kg plus tramadol 2 mg/kg (Ultram; Vertical Pharmaceutical, USA) in the TR group. Following the caudal block, the neuromuscular blockade was reversed (by atropine and neostigmine) and tracheal extubation was performed. The patients were assessed at determined times (1, 2, and 6 hours after the operation), and if the pain score was more than 3, acetaminophen 15 mg/kg (Paracetamol Zolben, Switzerland) would be i.v. injected. Before and after the caudal injection, the pain scores were assessed using CHEOPS (Children’s Hospital of Eastern Ontario Pain Scale), and non-invasive blood pressure and heart rate monitoring were observed (
Table 1). Moreover, the length of analgesia (pain score less than three), total acetaminophen used, post-anesthetic care unit stay (recovery time), and complications were evaluated.
| Score | 0 | 1 | 2 |
|---|
| Cry | No cry | Crying, moaning | Scream |
| Facial | Smiling | Composed | Grimace |
| Verbal | Positive | None or other complaints | Pain complaint |
| Torso | Neutral | Shifting, tense, upright | Restrained |
| Legs | Neutral | Kicks, squirm, drawn up | Restrained |
Data were analyzed by SPSS 25. The results were expressed as the mean ± standard deviation (SD) for parametric data (weight, age, pain score, length of pain relief, surgery duration, amount of acetaminophen consumption, blood pressure, and heart rate) and percentage for non-parametric data (sex, complications). Parametric data were compared using the independent t test if the data distribution was normal; alternatively, the comparison was carried out employing the Mann-Whitney U test if there was an abnormal distribution. Non-parametric data were also compared using the χ2 test or Fisher's exact test. A p value of less than 0.05 was considered statistically significant.